Allison Lauterbach Dale

Allison Lauterbach Dale

Associate

San Francisco, (415) 268-6349

Education

Brown University (B.A., 2005)
University of Southern California (M.A., 2009)
University of Southern California (Ph.D., 2014)
University of California, Berkeley, School of Law (J.D., 2014)

Bar Admissions

California

Allison Lauterbach Dale is a member of the firm’s Technology Transactions Group, working with clients in the high-tech and life sciences industries on intellectual property matters regarding licensing, product development, and complex and cross-border transactions, including joint development projects and mergers and acquisitions.

Dr. Lauterbach Dale has an extensive background in reproductive health law. She received her Ph.D. in history from the University of Southern California, where she specialized in 20th and 21st century U.S. legal and political history, with a primary focus on reproductive health. She graduated from the University of California, Berkeley – School of Law (Boalt Hall), serving as the symposium editor of the Berkeley Journal of Gender, Law & Justice. She also holds an M.A. from the University of Southern California and a B.A. from Brown University.

Prior to joining the firm, Dr. Lauterbach Dale worked as an extern for the Honorable Jacqueline Scott Corley, Magistrate judge in the Northern District of California.

Alcon
Assisting the eye care division of Novartis on a major collaboration with Google to develop and commercialize a glucose-sensing contact lens for use by diabetic patients.
NASDAQ-listed pharmaceutical and stem cell therapy development company
Leading negotiations and drafting a patent license with a global chemical company for a NASDAQ-listed pharmaceutical and stem cell therapy development company.
Alcon
Assisting the eye care division of Novartis on a major collaboration with Google to develop and commercialize a glucose-sensing contact lens for use by diabetic patients.
NASDAQ-listed pharmaceutical and stem cell therapy development company
Leading negotiations and drafting a patent license with a global chemical company for a NASDAQ-listed pharmaceutical and stem cell therapy development company.

Email Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

©1996-2017 Morrison & Foerster LLP. All rights reserved.